Back to top
more

Core Laboratories (CLB)

(Real Time Quote from BATS)

$20.32 USD

20.32
206,752

+0.32 (1.60%)

Updated Jun 28, 2022 02:54 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.75%
2Buy18.15%
3Hold9.70%
4Sell5.35%
5Strong Sell2.45%
S&P50010.91%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (71 out of 251)

Industry: Oil and Gas - Field Services

Trades from $1

Zacks News

Core Laboratories (CLB) Up 2.6% Since Last Earnings Report: Can It Continue?

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Core Labs (CLB) Stock Down 3% Since Q1 Earnings & Sales Beat

Core Laboratories' (CLB) stock down 3% since the company's first-quarter earnings and revenues beat estimates.

Core Laboratories (CLB) Tops Q1 Earnings and Revenue Estimates

Core Laboratories (CLB) delivered earnings and revenue surprises of 33.33% and 3.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Is a Surprise Coming for Core Laboratories (CLB) This Earnings Season?

Core Laboratories (CLB) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline

Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nilanjan Choudhury headshot

Oil & Gas Stock Roundup: Oilfield Service Giants Decide to Move From Russia

Apart from Russia-related updates from Halliburton (HAL), Schlumberger (SLB) and Core Laboratories (CLB), there was news regarding The Williams Companies (WMB) and Eni (E) during the week.

Core Labs (CLB) Hit by Russia Conflict, Pegs Down Q1 View

In addition to the geopolitical risks, Core Laboratories (CLB) suffered operational hiccups after a much larger-than-usual number of its employees tested positive for COVID during the first quarter.

Core Laboratories (CLB) Moves 14.2% Higher: Will This Strength Last?

Core Laboratories (CLB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Why Is Core Laboratories (CLB) Up 7.1% Since Last Earnings Report?

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Core Labs (CLB) Q4 Earnings Meet Estimates, Revenues Surpass

Core Laboratories' (CLB) fourth-quarter earnings are on par with the consensus mark, while revenues beat estimates as a result of a strong performance in the Production Enhancement segment.

Core Laboratories (CLB) Meets Q4 Earnings Estimates

Core Laboratories (CLB) delivered earnings and revenue surprises of 0% and 1.52%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Core Laboratories (CLB) Reports Next Week: Wall Street Expects Earnings Growth

Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Schlumberger (SLB) Q4 Earnings and Revenues Beat Estimates

Schlumberger (SLB) delivered earnings and revenue surprises of 5.13% and 2.14%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

ExxonMobil (XOM) to Divest Iraq Assets After Receiving Approval

ExxonMobil's (XOM) divestment of its West Qurna 1 stake would follow its 32% interest sale last year in a key exploration block in Iraq's Kurdistan region.

Core Labs' (CLB) Stock Up 9.4% Despite Missing on Q3 Earnings

In the September quarter, Core Labs (CLB) generates $11.9 million as operating cash and its capex totals $3.1 million, leading to an $8.8-million free cash flow (FCF) recognition.

Core Laboratories (CLB) Q3 Earnings and Revenues Lag Estimates

Core Laboratories (CLB) delivered earnings and revenue surprises of -5.26% and -4.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Core Laboratories (CLB) Reports Next Week: Wall Street Expects Earnings Growth

Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Is Core Laboratories (CLB) Down 19.4% Since Last Earnings Report?

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Core Labs' (CLB) Q2 Earnings and Revenues Miss Estimates

In the June quarter, Core Labs (CLB) generates $9.5 million in operating cash and its capital expenditure totals $2.9 million, leading to a $6.6-million free cash flow (FCF) recognition.

Core Laboratories (CLB) Lags Q2 Earnings and Revenue Estimates

Core Laboratories (CLB) delivered earnings and revenue surprises of -5.26% and -0.09%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Core Laboratories (CLB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Schlumberger (SLB) Stock Jumps 7.7% on Uplifting Forecasts

Schlumberger (SLB) expects oil activities to improve in the coming days, which in turn is likely to boost the demand for oilfield services.

Core Laboratories (CLB) Up 33.5% Since Last Earnings Report: Can It Continue?

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Core Labs' (CLB) Q1 Earnings Beat Estimates, Revenues Miss

In the March quarter, Core Labs (CLB) generates $8 million in operating cash and its capital expenditure totals $2.8 million, leading to a $5.2-million free cash flow (FCF) recognition.

Core Laboratories (CLB) Q1 Earnings Top Estimates

Core Laboratories (CLB) delivered earnings and revenue surprises of 15.38% and -1.61%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?